- Abbott Laboratories (NYSE:ABT) is scheduled to announce Q4 earnings results on Wednesday, January 27th, before market open.
- The consensus EPS Estimate is $1.35 (+42.1% Y/Y) and the consensus Revenue Estimate is $9.95B (+19.7% Y/Y).
- Analyst expects gross margin of 58.4%.
- Over the last 2 years, ABT has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 2 downward.